IR@PKUHSC  > 北京大学公共卫生学院
学科主题公共卫生
Underuse of statins in patients with atherosclerotic ischemic stroke in China
Li Xi1; Gao Yan2,3; Li Jing2,3; Feng Fang2,3; Liu Jia-min2,3; Zhang Hai-bo2,3; Zhang Dan2,3; Hundei Wu-han-bi-li-ge2,3; Chen Fang4; Chen Yi-ping4; Chen Zheng-ming4; Landray, Martin4; Armitage, Jane4; Jiang Li-xin2,3; Li Li-ming1; HPS2-THRIVE China Grp
关键词hydroxymethylglutaryl-CoA reductase inhibitors ischemic stroke secondary prevention
刊名CHINESE MEDICAL JOURNAL
2012-05-20
DOI10.3760/cma.j.issn.0366-6999.2012.10.005
125期:10页:1703-1707
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
资助者Merck Co., Inc ; Merck Co., Inc
研究领域[WOS]General & Internal Medicine
关键词[WOS]CEREBROVASCULAR-DISEASE ; RANDOMIZED-TRIALS ; CHOLESTEROL ; EFFICACY ; SAFETY ; PARTICIPANTS ; METAANALYSIS ; SIMVASTATIN ; ATTACK
英文摘要

Background Well designed randomized trials and meta-analyses have clearly shown that statins reduce the risk of major vascular events, including ischemic stroke, in a wide range of patients and their routine use is recommended for patients at an increased cardiovascular risk. Survivors of a first ischemic stroke are at a risk of recurrence and of other vascular events and statins are generally recommended to reduce this risk. This study investigated how widely statins were being used for such patients in China.

Methods Totally 6422 patients with a history of ischemic stroke were identified by reviewing medical records at 51 highest-ranking hospitals in 14 cities in China, and invited to attend a screening clinic to assess eligibility for a randomized trial. Their current statin and other drug uses were recorded alongside clinical and demographic characteristics. Univariate chi-square test and multivariate Logistic regression were used to determine the factors associated with treatment.

Results Only 24% of these patients reported currently taking a statin. The most important predictor of statin use among these patients was prior history of coronary heart disease. History of diabetes or hypertension, as well as treated in university affiliated hospitals is related to increased use. The status had improved significantly during a 2-year period. Atorvastatin (40%) and simvastatin (39%) were the most commonly used.

Conclusions In China, statins are still underused for secondary prevention among survivors of ischemic stroke. Reasons for this poor use need to be understood in order to increase use of these evidence based therapies. Chin Med J 2012;125(10):1703-1707

语种英语
资助者Merck Co., Inc ; Merck Co., Inc
WOS记录号WOS:000305259500005
Citation statistics
Cited Times:10[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/65667
Collection北京大学公共卫生学院
作者单位1.Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China
2.Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis,China Oxford Ctr Int, Beijing 100037, Peoples R China
3.Peking Union Med Coll, Beijing 100037, Peoples R China
4.Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England
Recommended Citation
GB/T 7714
Li Xi,Gao Yan,Li Jing,et al. Underuse of statins in patients with atherosclerotic ischemic stroke in China[J]. CHINESE MEDICAL JOURNAL,2012,125(10):1703-1707.
APA Li Xi.,Gao Yan.,Li Jing.,Feng Fang.,Liu Jia-min.,...&HPS2-THRIVE China Grp.(2012).Underuse of statins in patients with atherosclerotic ischemic stroke in China.CHINESE MEDICAL JOURNAL,125(10),1703-1707.
MLA Li Xi,et al."Underuse of statins in patients with atherosclerotic ischemic stroke in China".CHINESE MEDICAL JOURNAL 125.10(2012):1703-1707.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Li Xi]'s Articles
[Gao Yan]'s Articles
[Li Jing]'s Articles
百度学术
百度学术Similar articles in
[Li Xi]'s Articles
[Gao Yan]'s Articles
[Li Jing]'s Articles
必应学术
必应学术Similar articles in
[Li Xi]'s Articles
[Gao Yan]'s Articles
[Li Jing]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.